Photo Credit: istock Medical Research Laboratory Meeting of diverse team of scientists discussing innovative biotechnology for advanced medicine[/caption]
Advanced screening techniques are changing healthcare by making it easier to find and treat diseases earlier. These new technologies are helping doctors and researchers improve the way they diagnose these diseases and create better treatments. A key area where these techniques are making a big impact is in antibody discovery. It helps scientists find important proteins that can be used to fight diseases like cancer and autoimmune disorders.
In this article, we’ll look at how advanced screening techniques are changing healthcare, how they help with antibody discovery, and what the future might hold for these technologies.
Source[/caption]
First aid kits, bandages, antiseptics, pain relievers, prescription medications, and personal protective equipment (PPE) are the most essential medical supplies. These items account for over 80% of basic medical needs in emergency and routine situations.
While this list covers the basics, it's important to keep reading because the specific medical supplies you need can vary significantly based on your situation – whether you're stocking a home first aid kit, preparing for a natural disaster, or equipping a medical facility. Understanding these scenarios will help you make better-informed decisions about which supplies to prioritize.
Source[/caption]
Spinal stenosis affects millions of people and its symptoms can range in severity, with some people not even knowing they have the condition. For people who experience symptoms, the good news is that there are a variety of treatment options available to help them return to a normal life. This article...
Dr. Arscott[/caption]
Karen Arscott, DO
Department of Medical Education
Geisinger Commonwealth School of Medicine
Scranton PA 18509
MedicalResearch.com: What is the background for this study?
Response: “Substance Use Disorder Risk Assessment (SUDRA)” is a proposed screening tool and possible source of prevention for substance use disorder (SUD) and alcohol use disorder (AUD). The US opioid overdose epidemic continues to escalate with over one-hundred thousand deaths in a single year. The current screening tools used for assessing SUD identifies persons already suffering with advanced disease. Our investigation brings to light a simple screening tool which can be used to identify a person with “Preaddiciton” potential.
For many years I have asked persons (both patients and nonpatients) the question how they felt the first time they took an opioid. Their answers have been astonishing. Probably the one answer that struck me the strongest was a professional colleague who answered that when she was prescribed Vicodin following a surgical procedure it made her feel so amazing that it scared her, and she never took another opioid. She reported to me that it would have been too easy to take regularly for the wonderful feeling – she however, recognized the danger of that feeling and avoided a potential substance use disorder. What if this risk was provided to all – what if parents and patients understood the risk if faced with that “feeling”? How many lives could be saved?
We are very confident that these timely findings will be discussed and presented widely. The paper will be highly downloaded and cited by many interested in the prevention of substance use disorder – a new concept and much improved over the current treatment of advanced disease.
Dr. Jaswa[/caption]
Eleni G. Jaswa, MD, MSc
Assistant Professor, Ob/Gyn, Reproductive Science
UCSF
MedicalResearch.com: What is the background for this study?
Response: Some infections during pregnancy have been associated with abnormal neurodevelopment in children. This is likely due to the infection itself, or the maternal immune system response to infection. We sought to determine whether maternal COVID-19 infection during pregnancy, a now common occurrence, was associated with changes in children's neurodevelopment out to 24-months-old, compared to control children not exposed to maternal COVID-19 in utero.
Frank F Zhou[/caption]
Frank F. Zhou | he/him
MD Candidate, Class of 2025
David Geffen School of Medicine at UCLA
MedicalResearch.com: What is the background for this study? What is Lecanemab used for? How is it given to patients?
Response: Lecanemab is a new infusion therapy for Alzheimer's disease. Its dosing is based on each patient's body weight (10 mg/kg every two weeks), but the drug is only available in 500 mg and 200 mg single-use vials, meaning that any leftover drug in vials must be thrown away. Given that lecanemab is expected to cost Medicare billions of dollars each year, we hypothesized that discarded drug could result in significant wasteful spending.
Dr. Nguyen[/caption]
David-Dan Nguyen MDCM MPH Doctoral Student Institute of Health Policy Management and Evaluation and Resident Physician Division of Urology University of Toronto
MedicalResearch.com: What is the background for this study? Response: Peer reviewers are crucial to the academic publishing process. While there’s been significant scrutiny of potential conflicts of interest among authors and editors of major journals, the potential for conflicts of interest among peer reviewers has been relatively unexplored. As such, our study aimed to quantify and characterize industry payments made to peer reviewers of top medical journals—The BMJ, JAMA, The Lancet, and The New England Journal of Medicine—to better understand the extent of these financial relationships.
Dr. Hazen[/caption]
Stanley Hazen, MD, PhD
Chair, Cardiovascular & Metabolic Sciences
Lerner Research Institute
CoSection head, Preventive Cardiology & Cardiovascular Rehabilitation
Heart, Vascular and Thoracic Institute
Cleveland Clinic
MedicalResearch.com: What is the background for this study?
Response: One of the unique features of COVID is that in some subjects, there unfortunately appear to be long term adverse effects that can occur following resolution of the acute infection. These studies add to the growing body of data showing that COVID-19 infection can enhance risk for experiencing adverse cardiac events (heart attack, stroke, and death) over time.
Prof. Ahn[/caption]
Jiyoung Ahn, PhD
Professor of Population Health, NYU Grossman School of Medicine
Associate Director for Population Science, NYU Perlmutter Cancer Center
NYU Langone Health
Smilow Research Building
New York, NY 10016
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: We found that oral bacterial species are linked to a collective 50% increased risk of developing head and neck squamous cell carcinoma (HNSCC). Some of these microbes have previously been shown to contribute to periodontal disease, a serious gum infection that can erode the jawbone and the soft tissues surrounding the teeth.
Dr. Nas[/caption]
Dr Zeynep Nas Ph.D.
Postdoctoral Research Fellow
Department of Behavioural Science and Health
Institute of Epidemiology & Health Care
University College London
MedicalResearch.com: What is the background for this study?
Response: We were interested in why some children are more selective in their food intake and more reluctant to try new foods compared to those who are not. We investigated this question in a twin study, which compares identical twins (who share all of their genes) to non-identical twins (who share half) to understand the relative influence of genetics versus the environment in shaping individual differences in fussy eating.
Prof. Mihaylova[/caption]
Borislava Mihaylova, DPhil
Associate Professor & Senior Health Economist
Nuffield Department of Population Health, University of Oxford,
UK & Professor of Health Economics
Wolfson Institute of Population Health
Queen Mary University of London, UK
MedicalResearch.com: What is the background for this study?
Response: Despite high risks of heart disease and stroke in people over 70 years old and high need for preventive treatment such as statins, fewer older people use statins [compared to middle-aged people]. This, at least in part, is likely due to fewer older people, particularly those without previous heart attacks and strokes, included in the randomized studies of statin treatment. This has led to more limited evidence among them with larger uncertainty. Thus, we set to re-examine the value of statin treatment using the latest evidence and contemporary population data.
Source[/caption]
Image Source[/caption]

Source[/caption]
Response: Since 1945, the use of fluoride has been a successful public health initiative for reducing dental cavities and improving general oral health of adults and children. There is a concern, however, that some pregnant women and children may be getting more fluoride than they need because they now get fluoride from many sources including treated public water, water-added foods and beverages, teas, toothpaste, floss, and mouthwash, and the combined total intake of fluoride may exceed safe amounts.
Therefore, the National Toxicology Program (NTP) conducted a systematic review of the published scientific literature on the association between fluoride exposure and neurodevelopment and cognition. The NTP released their findings in a State of the Science Monograph on August 21, 2024, and posted to the NTP website. A corresponding meta-analysis on children’s IQ has been accepted by a scientific journal for publication later in 2024.
The NTP started this work in 2016. As with all research documents intended for publication, the NTP fluoride monograph and meta-analysis underwent rigorous scientific evaluation. The evaluation process has involved many steps. The draft fluoride monograph received significant critical feedback during peer-review by the National Academies of Science, Engineering and Medicine (NASEM), from other external experts, and from experts in several federal health agencies. After modifications were made, additional evaluation following a rigorous scientific framework was conducted by subject matter experts organized by the NTP Board of Scientific Counselors. I am very pleased that this document is now complete and available for reference.
Since fluoride is such an important topic to the public and to public health officials, it was imperative that we made every effort to get the science right. I commend the report authors, the NTP Board of Scientific Counselors, and countless subject matter experts who participated in this evaluation. The monograph represents a thorough review of the data, and the various interpretations of the data, to accurately reflect what we know and where additional research is needed.
Dr. Dias[/caption]
Caroline Dias, M.D., Ph.D.
Assistant Professor, Pediatrics-Developmental Pediatrics
University of Colorado Anschutz Medical Campus
[caption id="attachment_62962" align="alignleft" width="150"]
Dr. Walsh[/caption]
Christopher Walsh, M.D., Ph.D.
Chief, Division of Genetics and Genomics
Bullard Professor of Pediatrics and Neurology at Harvard Medical School
and researcher who has used material donated to the brain bank
MedicalResearch.com: What is the background for this study?
Response: Many different types of genetic variants contribute to neurodevelopmental disorders such as autism. Copy number variants are large pieces of genetic material that are duplicated or deleted. We have known for many years that many copy number variants at certain genetic locations are linked to autism. Because these copy number variants may include lots of different genes, it has been difficult to understand how these copy number variants alter human brain function. Furthermore, although animal models are important, autism is in many ways defined by differences in uniquely human cognitive and social functioning. Better understanding of how these copy number variants change human brain function will shed light on universal mechanisms that regulate neurodevelopment. We studied a copy number variant called dup15q, that is associated with almost 40-fold higher rates of autism vs. the general population. We studied post-mortem human brain tissue from individuals with dup15q, individuals with autism not related to dup15q, and neurotypical controls, to better understand how the human brain is impacted by dup15q. We focused on frontal cortex, an important brain region in executive function and social perspective taking. We applied cutting edge techniques that allow us to assess individual cells in the brain.
Dr. Davis[/caption]
Esa M. Davis, M.D., M.P.H , F.A.A.F.P
Professor of Medicine and Family and Community Medicine
Associate Vice President of Community Health and
Senior Associate Dean of pPopulation Health and Community Medicine
University of Maryland School of Medicine
Dr. Davis joined the U.S. Preventive Services Task Force in January 2021
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Iron is important to overall health, and people need more iron when they are pregnant. This can make pregnant people at increased risk for iron deficiency, which can progress to anemia and cause complications for both moms and their babies. After reviewing the latest available research, the Task Force found that there is not enough evidence on whether pregnant people who do not have signs or symptoms of iron deficiency or anemia should be screened—or take iron supplements—to improve their health or the health of their baby.
Dr. Oliva[/caption]
Azahara Oliva PhD
Assistant Professor
Department of Neurobiology and Behavior
Cornell University
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: The background is that we knew for a while now that neurons work hard to consolidate into memories each experience that we have during the day. But at the same time, it is known that sleep restore activity of our body and physiology. How was that possible? How can the neurons in our brain "work hard" during the time that we are supposed to be restoring our vitals? We found that in between their hard work, during sleep, our neurons take "breaks of activity" so our brain can build memories with precision.
Luke Cavanah[/caption]
Luke Cavanah, BS
Department of Medical Education
Geisinger Commonwealth School of Medicine
Scranton, PA 18509
MedicalResearch.com: What is the background for this study?
Response: Amphetamine, lisdexamfetamine, and methylphenidate, are first-line treatments for attention-deficit hyperactivity disorder (ADHD) and are classified as Schedule II stimulants due to their risk of addiction. (1–3) There has been high and increasing use and misuse of these medications with inadequate explanation. (4) Since chronic cannabis use can result in similar cognitive effects as ADHD 5–7, we wondered if more stimulants were prescribed for what appeared to be ADHD but was a consequence of chronic cannabis use. In other words, has the legalization of cannabis contributed to this inadequately explained increase in stimulant use? A recent study by our lab group that looked at the slopes of stimulant distribution rates over time -- before and after medical cannabis legalization -- did not support this.(8)
Given the prevalence and increasing legalization of recreational cannabis, we wanted to determine how slopes of stimulant distribution rates compared before and after recreational cannabis legalization.
To maximize your CBD experience, monitor the effects closely and adjust your usage as needed. Different people can react differently to CBD, and what works for one person might not work for another...
Dr. Meena Rafiq[/caption]
Dr Meena Rafiq | Academic GP & Clinical Research Fellow
FRACGP MRCGP MBBS BSc MSc
Epidemiology of Cancer and Healthcare Outcomes (ECHO) Group, UCL
Department of General Practice, The University of Melbourne
UCL Department of Behavioural Science and Health
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Almost all patients with cancer will first see their GP with symptoms and half of these patients will have vague, non-specific symptoms. As a GP I know it can be challenging to pick up patients with possible cancer in a 10 minute GP appointment, especially if they have vague non-specific symptoms. We know that many of these patients are already having blood tests done by their GP. So, we wanted to see if any of these blood tests could be used to help pick up with patients who see their GP with vague abdominal symptoms like abdominal pain and bloating are most likely to have cancer and need to be urgently referred.
Imagine a world where your health plan is as unique as your fingerprint. That's not a far-off dream - it's happening right now. In 2022, the global wellness industry hit a staggering $5.6 trillion, showing just how much people care about their health.
But here's the thing: we're all different. What works for your neighbor might not work for you. That's where personalized wellness plans come in, and they're getting a big boost from technology.
Think of it as having a super-smart health coach in your pocket. Thanks to AI in healthcare, we can now crunch huge amounts of data to create health plans that fit you perfectly. From your DNA to your daily habits, these tech tools consider it all.
This article will explore how these amazing technological advancements are changing the game in wellness. We'll see how they're making it possible to create health strategies that are truly tailored to you, helping everyone live their best, healthiest life.
An early diagnosis can profoundly affect a patient's quality of life. With early intervention, patients can adopt lifestyle changes, engage in targeted therapies, and access medications that help manage symptoms, potentially extending their years of independence....
AI is set to change how we handle ongoing health problems even more in the future. New AI tools are being made that could spot health issues before they become serious. AI could make it easier for doctors to keep track of how patients are doing, even when they're...
Dr. Gus Alva[/caption]
Gus Alva, MD, DFAPA
Medical Director, ATP Clinical Research
Medical Director, Senior Brain Health, Hoag Hospital, Newport Beach,
Assistant Professor, Department of Psychiatry and Neuroscience
University of California, Riverside, CA
MedicalResearch.com: What is the background for this study?
Response: This trial evaluated the effects of pimavanserin compared to placebo in frail older adults and elderly patients with neuropsychiatric symptoms related to Neurodegenerative disorder (NDD), such as hallucinations and delusions, to better understand the safety of pimavanserin in this population.
The study was a phase 3b, 8-week treatment (study duration of up to 16 weeks) with the primary endpoint being safety and tolerability, measured by treatment-emergent adverse events (TEAEs). Secondary safety endpoints were change from baseline in motor and cognitive function; exploratory endpoints included suicidality, sleep quality, and neuropsychiatric symptoms.
The reason for doing this study is that there is a high degree of interest in further understanding the safety of pimavanserin, as many antipsychotics used off label often have significant and serious adverse effects, including risk of falls, parkinsonism, and death.
Prof. Oram[/caption]
Prof. Richard Oram PhD
Associate Professor, Diabetes UK Harry Keen Fellow
Institute of Biomedical and Clinical Science and
NIHR Exeter Clinical Research Facility
University of Exeter
MedicalResearch.com: What is the background for this study?
Response: In contrast to most autoimmune diseases, male sex is a risk factor for type 1 diabetes (T1D). This raises the hypothesis that either immune, metabolic, or other differences between sexes may impact risk or progression through stages of T1D. However, understanding the mechanisms for this could inform future interventions or risk stratification of individuals at-risk of T1D.